Advanced Glaucoma Care in Gurgaon

Looking for advanced glaucoma care in Gurgaon? Dr Shibal Bhartiya provides expert diagnosis, risk stratification, second opinions, and long-term glaucoma management focused on preserving vision safely over time. Glaucoma can progress silently even when vision feels normal. Advanced glaucoma care combines detailed testing, risk stratification, continuity of follow-up, and individualized treatment planning to reduce the risk of preventable vision loss.

Advanced glaucoma care in Gurgaon requires more than a pressure check and a prescription. It requires structural analysis, individualised progression mapping, and a specialist with the training to catch damage before your vision notices it. That specialist should have fellowship-level expertise -not just general ophthalmology experience.

Most patients arrive at a glaucoma consultation after one of two experiences: a routine eye test that flagged something unexpected, or months of treatment that doesn’t feel like it’s working. Both are disorienting. Glaucoma is a condition where the stakes are permanent, lost nerve fibres do not return, and yet most early-stage patients feel completely normal. That gap between invisibility and irreversibility is exactly why the quality of your specialist matters more than in almost any other eye condition.

This page is not a list of credentials. It is a plain-language explanation of what advanced glaucoma management actually involves, so you can ask the right questions, in any clinic, including mine.


What Makes Glaucoma Management Genuinely Complex

Glaucoma is not one disease. It is a family of conditions: each with different pressure profiles, different structural signatures, and different rates of progression. Managing it well requires training that goes beyond what a general ophthalmologist receives.

Pressure is necessary, but not sufficient

Intraocular pressure (IOP) is the most controllable risk factor in glaucoma. But roughly 30–40% of glaucoma patients in India have pressures that fall within the “normal” range. A specialist who treats only the number, and misses the nerve, will miss the disease.

Structural progression requires trained interpretation

OCT (optical coherence tomography) scans generate data that is only as useful as the clinician reading it. Retinal nerve fibre layer thinning, ganglion cell loss, and optic disc changes must be interpreted in the context of your age, disc anatomy, and longitudinal trend. A single scan means very little. A series of scans, read by someone who knows what they are looking for, means everything.

24-hour IOP behaviour matters

IOP fluctuates across the day and night. A single clinic reading captures one moment. Fellowship-trained glaucoma specialists are trained to account for diurnal variation, peak pressure timing, and nocturnal dips: factors that can determine whether a patient progresses despite apparently controlled pressures. This is an area where I have published peer-reviewed research.

Treatment decisions are not linear

Drops, laser, MIGS (minimally invasive glaucoma surgery), and filtration surgery each have a specific place in a well-structured management plan. Choosing the right intervention, and the right sequence, requires experience with the full treatment spectrum, not just the tools a particular clinic happens to offer.


What to Look For When Choosing a Glaucoma Specialist in Gurgaon

This is the question most patients search for but rarely find answered honestly. Here is what actually differentiates a glaucoma subspecialist from a general eye doctor offering glaucoma care.

What to AskWhy It MattersWhat to Look For
Did the doctor complete a glaucoma fellowship?Fellowship training means 1–2 years of dedicated subspecialty immersion beyond residencyLook for fellowship credentials, not just MBBS + MS
Does the clinic offer 24-hour IOP monitoring?Single readings miss nocturnal pressure spikes that drive progressionAsk whether phasing or ambulatory IOP is available
Can the doctor interpret OCT trends across time?Structural progression is subtle and cumulativeAsk how many scans are needed before they track trends
Is MIGS offered — and appropriately selected?MIGS is not appropriate for every patient; over-recommendation is a red flagA good specialist will tell you when surgery is not yet needed
Does the specialist publish research?Research engagement means currency with evolving evidenceCheck PubMed, ORCID, or academic profiles

What Doctors Often Miss in Glaucoma Consultations

In over 25 years of glaucoma practice, these are the patterns I see most often in patients who arrive for a second opinion.

Normal pressure, missed diagnosis. Normal tension glaucoma is systematically underdiagnosed in India. Patients with pressures of 14–16 mmHg are reassured and discharged — while nerve fibre loss continues silently.

OCT reported as “stable” without longitudinal comparison. A single OCT is a photograph. Stability can only be determined by comparing photographs across time. Patients are sometimes told they are stable after one scan.

Ocular surface disease from drops, untreated. Long-term use of preserved glaucoma drops causes surface inflammation in a significant proportion of patients. This is rarely addressed proactively — and yet it affects adherence, comfort, and outcomes directly.

MIGS offered too early or too late. Minimally invasive glaucoma surgery has transformed the moderate-stage treatment window. But it is not a substitute for medical therapy in early disease, and it is insufficient for advanced disease. Appropriate patient selection is a subspecialty skill.

Family history not taken seriously. First-degree relatives of glaucoma patients have a 4–9x elevated risk. Screening of siblings and children is rarely initiated proactively.


When to Seek a Second Opinion

Seek a second opinion if any of the following apply:

  • You have been on the same drops for more than two years with no formal progression assessment
  • Your visual field tests show worsening despite treatment
  • You were told your pressures are normal but your optic nerve looks “suspicious”
  • Surgery has been recommended and you want to understand all your options
  • You have a strong family history and want a baseline assessment from a subspecialist

A second opinion is not disloyalty to your current doctor. In a condition where the damage is permanent and irreversible, it is due diligence.


What This Means for You

If you are searching for the best glaucoma care in Gurgaon, the most important thing you can do is not look for a superlative — it is to look for a subspecialist. Fellowship training, peer-reviewed research, and a structured approach to progression monitoring are the markers that distinguish subspecialty glaucoma care from general ophthalmology practice.

I am a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience managing glaucoma across its full spectrum — from early suspect to advanced disease requiring surgical intervention. My practice at Marengo Asia Hospitals, Sector 56, Gurugram is built around catching damage before it becomes irreversible, and around ensuring that every treatment decision is grounded in your individual risk profile — not a protocol.

If you would like a structured assessment or a second opinion on your current management, I am available for consultation.

📞 +91 88826 38735 | 🌐 www.drshibalbhartiya.com


Frequently Asked Questions

How do I choose the best glaucoma specialist in Gurgaon?

Look for a doctor who completed a dedicated glaucoma fellowship — not just general ophthalmology training. The best glaucoma specialists offer structural progression monitoring with OCT, account for 24-hour pressure behaviour, and have experience across the full treatment spectrum including MIGS and filtration surgery. Research publications are a reliable indicator of subspecialty currency.

What is the difference between a glaucoma specialist and a general eye doctor?

A glaucoma specialist has completed additional fellowship training — typically one to two years — focused exclusively on glaucoma diagnosis, medical management, laser, and surgery. A general ophthalmologist can manage straightforward cases but may lack the training to detect subtle progression, interpret complex OCT trends, or select patients appropriately for MIGS.

Is Dr Shibal Bhartiya the best glaucoma doctor in Gurgaon?

Dr Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience and 90+ PubMed-indexed publications. She offers subspecialty glaucoma care including second opinions, advanced surgical options including MIGS, and 24-hour IOP assessment at Marengo Asia Hospitals, Sector 56, Gurugram. Patients are encouraged to review her published research and make their own assessment.

What should I look for when seeking the best doctor for MIGS surgery in Gurgaon?

MIGS, minimally invasive glaucoma surgery, requires a surgeon with specific training in device selection, patient eligibility assessment, and intraoperative technique. Ask whether your surgeon has published on MIGS outcomes, can explain why you are or are not a candidate, and offers filtration surgery as an alternative if MIGS is insufficient for your disease stage.

Can I get a glaucoma second opinion in Gurgaon?

Yes. Second opinions for glaucoma are available at Marengo Asia Hospitals, Sector 56, Gurugram. Bring your previous OCT scans, visual field reports, and current prescription to your appointment. A structured second opinion typically includes a full structural assessment, pressure evaluation, and review of your current management plan.


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

1500+ Five Star Patient Reviews Google Business Profile

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Read her research on PubMed | Google Scholar | ResearchGate | ORCID

Upload your reports for a structured review.| www.drshibalbhartiya.com | +91 88826 38735

Leave a review on Google


Family History & Glaucoma Screening

Family History & Glaucoma Screening– My Parent or Sibling Has Glaucoma. Do I Need to Get Tested Too? Short answer, YES. Having a first degree relative with glaucoma: a parent, sibling, or child, raises your lifetime risk of developing the disease by four to nine times compared to someone with no family history, says Dr Shibal Bhartiya.

Your parent or sibling has just been diagnosed with glaucoma. Or perhaps they have had it for years and you are only now realising what that means for you.

You are asking the right question. Most people do not ask it until it is too late. Dr Shibal Bhartiya explains more.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Why Family History Changes Everything in Glaucoma

Glaucoma is not random. It runs in families. Having a first degree relative with glaucoma: a parent, sibling, or child, raises your lifetime risk of developing the disease by four to nine times compared to someone with no family history.

That is not a small increase. That is a fundamental shift in your risk category.

And yet most first degree relatives of glaucoma patients never get tested. They wait for symptoms. Glaucoma does not produce symptoms until significant, often irreversible damage has already occurred. By the time your vision changes, the window for early intervention has often narrowed considerably.

This is why family history glaucoma screening exists: not to frighten you, but to find the disease before it finds you.


What Is the First Degree Relative Glaucoma Risk?

A first degree relative is a parent, sibling, or child: someone who shares approximately 50 percent of your genetic material.

The first degree relative glaucoma risk is well established in research. Studies consistently show that having one affected first degree relative raises your risk of developing primary open angle glaucoma to approximately 1 in 5. Having two affected first degree relatives raises it further.

The risk is highest when the affected relative developed glaucoma before the age of 60, when the disease was severe at diagnosis, or when the relative required surgery rather than drops alone.

First degree relative glaucoma risk is also higher in specific ethnic groups. People of African descent carry a higher baseline risk. In India, primary angle closure glaucoma has a higher prevalence than in Western populations, and this pattern also clusters in families.

Knowing your family history is not just useful. In glaucoma, it is clinically essential.


Does Having a Family History Mean You Will Definitely Get Glaucoma?

No. A family history raises your risk. It does not guarantee disease.

Many people with a strong family history never develop glaucoma. Many develop it only in their seventies or eighties, when treatment is straightforward and vision loss is entirely preventable with monitoring.

What family history means clinically is this: you belong in a higher-risk group that benefits from earlier, more frequent screening for glaucoma. That is all. It is not a sentence. It is a schedule.


Glaucoma Risk Factors Beyond Family History

Family history is the single strongest glaucoma risk factor after age. But it does not act alone. Several other glaucoma risk factors combine with family history to raise your personal risk further.

Age is the most consistent glaucoma risk factor across all populations. Risk rises steeply after 40 and continues to increase with each decade.

Raised eye pressure, also called ocular hypertension, is a major modifiable glaucoma risk factor. Not everyone with high eye pressure develops glaucoma, but the risk is substantially elevated, particularly when combined with family history.

Myopia (near-sightedness) increases glaucoma risk, particularly for primary open angle glaucoma. Moderate to high myopia is an independent glaucoma risk factor.

Thin corneas reduce the accuracy of eye pressure measurements and are independently associated with glaucoma progression risk.

Systemic conditions including diabetes, hypertension, and migraine are associated with higher glaucoma risk in some studies, particularly for normal tension glaucoma.

Previous eye injury or steroid use — whether eye drops, inhalers, skin creams, or oral steroids — can raise eye pressure and trigger steroid-induced glaucoma, particularly in genetically susceptible individuals.

When you combine a family history of glaucoma with one or more of these additional glaucoma risk factors, the case for early screening becomes compelling.


What Does Screening for Glaucoma in Adults Actually Involve?

Screening for glaucoma in adults is not a single test. It is a short, structured examination that covers the four main parameters of glaucoma assessment.

Eye pressure measurement — intraocular pressure is measured using a non-contact tonometer or applanation tonometry. This takes less than a minute. It is painless.

Optic nerve assessment — the ophthalmologist examines the optic disc through a dilated pupil or with specialist lenses. The size, shape, and symmetry of the optic nerve head are evaluated. This is the most important part of any glaucoma screening examination.

Corneal thickness measurement — pachymetry measures corneal thickness, which affects the interpretation of eye pressure readings.

OCT imaging — optical coherence tomography of the RNFL and optic nerve head provides structural data that can detect early glaucoma damage before any symptoms or visual field changes occur. You can read more about what an OCT scan shows and how to interpret your report.

Visual field testing — in higher-risk individuals, a visual field test maps peripheral and central vision to detect any functional loss.

Gonioscopy — in patients where angle closure is suspected, gonioscopy examines the drainage angle of the eye. This is particularly relevant in Indians, where angle closure glaucoma is more prevalent.

A complete screening for glaucoma in adults takes approximately 45 to 60 minutes at a specialist glaucoma clinic, including dilation time.


When Should Screening for Glaucoma Early Begin?

The timing of screening for glaucoma early depends on your personal risk profile.

For most adults with a first degree relative with glaucoma and no other risk factors, screening should begin at 40. Some guidelines recommend starting at 35 in high-risk ethnic groups or when the affected relative had early-onset disease.

For adults with a family history plus additional glaucoma risk factors: high myopia, raised eye pressure found incidentally, or very thin corneas, earlier screening is warranted. In these cases, a baseline examination in the mid-thirties is reasonable.

For adults with no family history and no other risk factors, screening for glaucoma in adults is generally recommended from the age of 40 as part of a routine comprehensive eye examination.

The question is not whether to screen. The question is when to start and how often to repeat.


How Often Should You Be Screened?

Frequency depends on what the first examination shows.

If the first screening is entirely normal: normal eye pressure, healthy optic nerve, normal OCT, annual or biennial review is appropriate for most people in the family history risk group.

If the first screening shows borderline findings: slightly elevated pressure, a suspicious optic disc, or mildly thin RNFL on OCT, more frequent monitoring is needed. Your glaucoma specialist will advise a specific schedule based on your individual findings.

If the first screening confirms early glaucoma, you move from a screening pathway to a treatment and monitoring pathway. Early glaucoma detected through family history glaucoma screening is almost always manageable, and vision loss is highly preventable with timely intervention.


Detecting Glaucoma Early: Why It Matters So Much

Glaucoma destroys retinal nerve fibres. Once those fibres are gone, they do not regenerate. The vision lost to glaucoma does not return.

Detecting glaucoma early changes the entire trajectory of the disease. A patient diagnosed at the very beginning of structural damage, before any visual field loss, has an excellent long-term prognosis with appropriate treatment. A patient diagnosed after significant optic nerve damage faces a harder, narrower path.

The difference between these two patients is often not biology. It is timing. It is whether someone in the family said: you should get checked, and whether the person listened.

Detecting glaucoma early through structured family history screening is one of the highest-value interventions in all of preventive ophthalmology. It costs very little. It changes lives.


What Happens If Glaucoma Is Found?

Finding glaucoma early through family history glaucoma screening is not bad news. It is good news delivered at the right time.

Early glaucoma in a screened patient is almost always managed with eye drops alone. Treatment is started, eye pressure is brought to a safe target, and the optic nerve is monitored regularly. Most patients with early glaucoma, managed well and consistently, never develop significant visual impairment.

The goal of glaucoma treatment is not to cure the disease. It is to slow it so completely that it never affects your quality of life. That goal is realistic. It is achieved every day for patients who are found early.

What changes if glaucoma is found is not your life. It is your schedule, a few extra clinic visits and a bottle of eye drops. That is the trade. For preserved vision over decades, it is a very good trade.


What If the Screening Is Normal?

A normal screening result is genuinely reassuring, but it is not a permanent all-clear.

Glaucoma can develop or progress at any age. A normal result at 40 means you do not have glaucoma now. It does not mean you will never develop it. This is why regular, repeated family history glaucoma screening matters more than a single normal result.

Think of it the way you think of blood pressure checks or dental appointments. A normal result today schedules your next check. It does not cancel all future checks.


Where to Get Screened in Gurgaon

If you have a family history of glaucoma and have not yet been assessed, a structured glaucoma risk evaluation with a glaucoma specialist in Gurgaon is the right next step.

A specialist assessment goes beyond a basic eye pressure check. It includes optic nerve imaging, corneal thickness measurement, OCT analysis, and visual field testing, and if indicated, gonioscopy. This gives you a complete, documented baseline against which future examinations can be compared.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram. She offers structured glaucoma risk assessments for patients with a family history of glaucoma, including those seeking a second opinion on existing results or diagnoses.

Appointments: +91 88826 38735

Upload your reports for a structured review.


Gentle Takeaway

Your parent’s diagnosis is information. It is not fate.

The single most useful thing you can do with that information is act on it earlybefore symptoms, before damage, before the window narrows.

Glaucoma caught early is a very manageable disease. Glaucoma caught late is a much harder conversation. The difference is often a single timely appointment.

Book one.

Family History as a Glaucoma Risk Trigger, Not a Footnote

A positive family history remains one of the most clinically actionable risk signals in glaucoma, yet also one of the most under-leveraged.

First-degree relatives of patients with glaucoma have a substantially higher lifetime risk (often 3–4× or more), and importantly, may develop disease earlier and with more aggressive trajectories.

Dr Bhartiya’s editorial along with geneticists from AIIMS, New Delhi and Marengo Asia, emphasises on integrating genomics into practice (PMID: 41523176), reinforcing that family history is not merely a background detail but a proxy for inherited susceptibility that should actively trigger structured screening pathways.

In practical terms, this shifts glaucoma care from opportunistic detection to targeted risk-based screening, where identifying and counselling family members becomes a core extension of clinical responsibility, not an optional add-on.

Clinical Reality (Family History & Glaucoma Screening in India)

  • Family history is one of the strongest risk factors — but often ignored
    Many patients only realise its importance after damage has already occurred.
  • Screening is not routine for relatives
    Unlike diabetes or hypertension, glaucoma screening is rarely proactively advised to family members.
  • “No symptoms” delays first check
    High-risk individuals often wait for visual complaints, by which time disease may already be advanced.
  • Normal eye check-ups may miss early glaucoma
    Routine vision tests without optic nerve evaluation or fields can miss disease.
  • Younger family members are often overlooked
    Screening is delayed until later decades, despite risk beginning earlier.
  • One normal test gives false reassurance
    A single normal OCT or pressure reading does not rule out future risk.

What Good Screening Looks Like (If You Have a Family History of Glaucoma)

  • Early baseline screening — before symptoms
    Ideally by age 30–40, or earlier if multiple affected relatives.
  • Comprehensive evaluation, not just vision or pressure
    Includes optic nerve assessment, OCT, visual fields, corneal thickness.
  • Risk-stratified follow-up
    Frequency depends on baseline findings — not “come if needed.”
  • Family-based screening approach
    First-degree relatives (parents, siblings, children) are actively advised evaluation.
  • Longitudinal monitoring
    Tracking change over time is key — not single reports.
  • Clear patient education
    Understanding risk improves adherence to follow-up and screening.

Family History & Glaucoma Screening: What’s Missed vs What Matters

SituationWhat Patients Often AssumeClinical Reality (India Context)What Good Care Looks Like
Family history present“It’s not affecting me yet”Risk is significantly higher even without symptomsEarly baseline screening for all first-degree relatives
No symptoms“I’ll get checked if I notice a problem”Glaucoma remains silent until irreversible damageScreening before symptoms begin
Routine eye check-up“My eyes were checked, so I’m fine”Standard vision tests may miss early glaucomaComprehensive glaucoma evaluation (OCT + fields + nerve exam)
Age factor“I’m too young to worry”Risk can begin earlier in those with family historyScreening from 30–40 years or earlier if high risk
Single normal report“Everything was normal last time”One test cannot rule out future progressionPeriodic follow-up based on risk profile
Family awareness“No one told my family to get tested”Screening advice is often not extended to relativesProactive, family-based screening approach
Follow-up“I’ll come back if needed”Irregular follow-up delays detection of early changesStructured, risk-based follow-up intervals
Understanding risk“It’s just genetic, nothing to do now”Early detection can prevent vision lossEducation + long-term monitoring strategy
Disease perception“Glaucoma means high pressure only”Many patients develop glaucoma at normal pressuresBroader risk assessment beyond IOP
Goal of screening“Just to rule it out”Screening is about early detection and tracking changeLong-term risk management, not one-time clearance

Frequently Asked Questions: Family History and Glaucoma Screening

Does glaucoma run in families?

Yes. Having a first degree relative: a parent, sibling, or child with glaucoma raises your lifetime risk of developing the disease by four to nine times. Family history is the single strongest glaucoma risk factor after age. Structured family history glaucoma screening is recommended for all first degree relatives of glaucoma patients.

What is the risk of glaucoma if a parent has it?

The first degree relative glaucoma risk is approximately 1 in 5 for primary open angle glaucoma, significantly higher than the general population risk of around 1 in 50. The risk is higher when the affected parent developed glaucoma early, had severe disease, or required surgery.

At what age should I get screened for glaucoma if a parent has it?

Screening for glaucoma early should begin at 40 for most adults with a first degree relative with glaucoma. Those with additional glaucoma risk factors, high myopia, raised eye pressure, or thin corneas, should consider a baseline examination from the mid-thirties.

What does glaucoma screening involve?

Screening for glaucoma in adults includes eye pressure measurement, optic nerve assessment through a dilated pupil, corneal thickness measurement, OCT imaging of the nerve fibre layer, and visual field testing in higher-risk individuals. A complete specialist assessment takes approximately 45 to 60 minutes.

Can glaucoma skip a generation?

Yes. The genetic inheritance pattern of glaucoma is complex and not fully understood. Glaucoma can skip generations or manifest differently across family members. A negative family history in your parents does not fully exclude risk if grandparents or siblings are affected.

What glaucoma risk factors increase my risk beyond family history?

Key glaucoma risk factors that combine with family history include age over 40, raised eye pressure, moderate to high myopia, thin corneas, diabetes, and previous steroid use. The more risk factors present alongside family history, the stronger the case for early and frequent screening.

If my glaucoma screening is normal, do I still need follow-up?

Yes. A normal result at first screening does not mean permanent all-clear. Glaucoma can develop at any point. Annual or biennial review is recommended for adults with a family history of glaucoma, even when the initial assessment is entirely normal.

Book a consultation with Dr Shibal Bhartiya:

Marengo Asia Hospitals, Gurugram

Phone: +91 88826 38735

Website: drshibalbhartiya.com

Google Business Profile: maps.app.goo.gl/mcfegmHTuhqV5hSp6

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Glaucoma Test Results Explained: OCT, Visual Fields and Eye Pressure

Glaucoma test results are interpreted by combining OCT (optic nerve structure), visual fields (functional loss), and eye pressure, not in isolation. Early glaucoma can show normal vision but abnormal OCT or subtle field changes, which is why expert interpretation matters. A report may appear “normal” in one test but still show early glaucoma in another, especially on OCT.
Early glaucoma often has no symptoms, so small structural or functional changes matter more than how clearly you see.

Quick Interpretation Guide

Key rule: No single test confirms glaucoma; patterns + progression matter

OCT scan: Detects thinning of the optic nerve (early damage can appear here first)

Visual field test: Shows blind spots or peripheral vision loss (functional impact of disease)

Eye pressure (IOP): A risk factor, not a diagnosis, can be normal in glaucoma

Optic nerve exam: Assesses cupping and structural changes

If results are borderline or conflicting, progression over time, not a single test, determines diagnosis and treatment decisions. Dr Shibal Bhartiya, glaucoma specialist in Gurgaon, offers structured second opinions to interpret reports and guide treatment decisions.

Most patients arrive at a glaucoma consultation holding something. A folder. A USB drive. A stack of printouts from three different centres.

And one question: Is this serious? Do I need treatment?

That question is exactly right. The reports alone, however, cannot answer it.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Why Your Glaucoma Reports Create More Confusion Than Clarity

Each glaucoma test measures something different. Understanding what each one measures matters before you can understand what it means.

OCT scans measure structure. They calculate the thickness of the nerve fibre layer in your retina. Visual field tests measure function. They map what you can actually see and where gaps exist. Eye pressure is a risk factor, not a diagnosis. It can be elevated in people without glaucoma and normal in people who have it.

Looking at any one of these tests in isolation is misleading. Doctors who rely on a single test or a single visit miss what glaucoma actually is: a disease defined by change over time, not by a number on a report.


The Biggest Mistake Patients and Doctors Make

The most common mistake is treating a single report as the final word.

One abnormal OCT does not confirm glaucoma. One normal visual field does not rule it out. One eye pressure reading does not define your risk.

Glaucoma is not in the report. It is in the pattern over time.

A single snapshot, however detailed, tells you where you are today. It tells you nothing about where you are headed or how fast.


What Actually Matters When Reading Glaucoma Test Results

Consistency across tests. Structure and function should agree. When they do not, that disagreement is itself a clinical finding.

Change over time. Progression, not an absolute number, is how glaucoma causes irreversible harm. A stable OCT at 80 microns is far less alarming than one that dropped from 100 to 80 over two years.

Correlation with clinical examination. Disc photographs, gonioscopy, pachymetry, and a detailed history all shape what the reports mean. Printouts do not replace an examination.

A baseline to compare against. Without a baseline reading, no one can determine whether your results are stable or worsening. Many patients have no baseline at all.


When Your Glaucoma Reports Should Be Questioned

Some combinations of findings create decision traps rather than answers.

Your OCT shows an abnormality, but your visual fields are completely clean. The visual fields show loss, but the OCT looks normal. Your results vary significantly across different centres. You have no baseline to compare your current tests against.

These situations are not unusual. They are also not something a report can resolve on its own. They require clinical interpretation from someone who understands how these tests interact, and what normal variation looks like across different machines, populations, and clinical settings.

These are decision traps. They are not answers.


Why Indian Patients Need India-Specific Interpretation

Most OCT normative databases are built on Western populations. Indian eyes differ in optic disc size, retinal nerve fibre layer thickness, and axial length.

A result flagged as abnormal on a Western normative database may be entirely normal for an Indian patient. The reverse is also true. This is one reason why reports sometimes generate unnecessary alarm, and why population-matched interpretation matters.


What a Specialist Glaucoma Review Actually Involves

When I review a patient’s test results, I ask a specific set of questions.

Do the OCT findings and visual field findings agree? If not, which is more likely to represent true disease? Is there a baseline to compare against, and if so, what is the rate of change? Does the optic nerve appearance on examination match the measurements? What does the full risk profile show: including age, family history, corneal thickness, and relevant systemic factors?

That analysis is different from reading a printout. It is clinical reasoning built on pattern recognition across thousands of patients and many years of subspecialty practice in glaucoma.


The Goal Is Interpretation, Not More Tests

More tests rarely resolve confusion from existing tests. They add data without adding understanding.

If your reports have given you more confusion than clarity, you do not need another scan. You need someone who can put what you already have into clinical context, and tell you, with precision, whether you need to act, wait, or watch.

That is what a glaucoma consultation is for.

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.


Frequently Asked Questions: Understanding Glaucoma Test Results

Can normal eye pressure mean I do not have glaucoma?

Yes. Normal tension glaucoma is well-recognised and accounts for a significant proportion of glaucoma cases in India and Asia. Eye pressure is a risk factor, not a diagnostic threshold. Many patients with glaucoma have eye pressure readings within the statistically normal range. This is why pressure alone cannot confirm or exclude a diagnosis.

What does a thin OCT reading actually mean?

A thin OCT reading means that the nerve fibre layer in your retina measures below average. It does not automatically mean glaucoma. Thin readings can reflect natural anatomical variation, myopia, previous inflammation, or other conditions. A single thin OCT result requires correlation with your visual field test, your optic nerve appearance, and your history before any conclusion is drawn.

Can glaucoma be missed on a visual field test?

Yes. Visual field tests have limitations. Early structural damage to the optic nerve often precedes detectable functional loss on a visual field test by months or years. A normal visual field result does not exclude early glaucoma. It means function is preserved at that point in time. Serial testing over time is needed to detect progression.

How often should glaucoma tests be repeated?

The frequency depends on your individual risk profile and whether glaucoma or a suspect diagnosis has been established. Patients with confirmed glaucoma typically need visual fields and OCT every six to twelve months. Glaucoma suspects may need annual review. Your specialist will guide this based on your progression risk.

Why do my results vary across different hospitals or centres?

OCT results vary across different machine brands, software versions, and normative databases. Visual field results vary with patient fatigue, technique, and learning effect. Variation across centres is common and does not always indicate a change in your condition. Comparing tests done on the same machine type, at the same centre, over time gives the most reliable information.

What is the difference between glaucoma and a glaucoma suspect?

A glaucoma suspect is someone who has one or more features that raise concern: elevated eye pressure, a suspicious optic nerve, a thin retinal nerve fibre layer, a family history, or an equivocal visual field, but who does not yet meet the criteria for a glaucoma diagnosis. Suspects require regular monitoring because some will convert to glaucoma over time and some will not. Distinguishing the two requires careful longitudinal review.

When should I seek a second opinion on my glaucoma reports?

Seek a second opinion if your OCT and visual field results disagree persistently, if you have been told surgery is needed but your vision seems unchanged, if your reports vary significantly across centres, or if you have no baseline and cannot determine whether your condition is stable. A second opinion from a fellowship-trained glaucoma specialist can clarify your diagnosis and give you confidence in your treatment plan.

About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine. This article was updated in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Glaucoma and the Silent Warning Symptoms

Early Glaucoma Has No Symptoms. So How Do You Know You Have It? Dr Shibal Bhartiya explains who is at…

Your Visual Field Test Results Explained

Your Visual Field Test Results Explained: What the Numbers Actually Mean. The test tells us how much, overall, your visual…